SAN FRANCISCO, Nov. 13 – Pfizer joined Accelrys’ High Throughput Crystallography Consortium, Accelrys announced Tuesday.

Princeton, N.J.-based Accelrys, a subsidiary of Pharmacopeia, created the consortium to explore and validate rapid methods for X-ray structure determination, model building, and structure validation, according to the company.  The agreement with Pfizer covers a number of sites, including Sandwich, UK, Groton, Ann Arbor and La Jolla.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.